Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,149 public trials 552 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin.

NCT01178996

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Hôpital Necker Paris, France

Universitätsklinikum Tübingen Tübingen, Germany

University Hospital of Ioannina Ioannina, Greece

Ospedale Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy

View Trial Details

Completed

A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa

NCT00971230

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations: Kenya Medical Research Institute, Center for Geographic Medicine Research - Coast Kilifi, Kilifi County, Kenya

Kenya AIDS Vaccine Initiative, University of Nairobi Nairobi, Nairobi County, Kenya

View Trial Details

Completed

A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B Infection

NCT01020565

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Not specified

View Trial Details

Completed

Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+

NCT01174914

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations: University Hospital of Point G Bamako, Mali

View Trial Details

Completed

A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a [40KD]) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C

NCT00394277

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Birmingham, Alabama, United States

Huntsville, Alabama, United States

Anchorage, Alaska, United States

Phoenix, Arizona, United States

View all 184 locations

View Trial Details

Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

NCT00353418

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial

NCT00615810

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Gilead Sciences Granta Park, Cambridge, Abington, United Kingdom

View Trial Details

Completed

Prognosis of Acute Coronary Syndrome in HIV-infected Patients

NCT00139958

Conditions: Acute Coronary Syndrome, Blood-Borne Infections, Cardiovascular Diseases, +19 more
Locations: Cardiology department Paris, France

View Trial Details

Completed

Impact of Nutrition Intervention on HIV/AIDS Infected Patients

NCT01171495

Conditions: Acquired Immune Deficiency Syndrome (AIDS), Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
Locations: Comprehensive Health Centre Kingston, Jamaica

View Trial Details

Completed

Physiologic Growth Hormone Effects in HIV Lipodystrophy

NCT00100698

Conditions: AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +21 more
Locations: MGH Boston, Massachusetts, United States

View Trial Details

Communicable Diseases

Communicable Diseases trial results

Related conditions